Skip to main content
Premium Trial:

Request an Annual Quote

Schering Licenses Inpharmatica's Kinase SARfari Knowledge Base

NEW YORK (GenomeWeb News) — Inpharmatica today said that Schering AG has obtained a multi-year, multi-user license to its Kinase SARfari knowledge base.
 
The product covers the biology and chemistry of the major group of successful targets in drug discovery, and Schering will use it as part of its drug-discovery process in the field of protein kinases, Inpharmatica said.
 
Financial terms were not disclosed.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.